positionForPages[47]={page:47,positions:[{w:"Vol. 1 - Issue 2",p:[0.743337,0.965677,0.857137,0.965677,0.857137,0.947594,0.743337,0.947594,0.011649,0.009239,0.005137,0.004620,0.004620,0.009239,0.004620,0.006153,0.004620,0.007188,0.007188,0.007188,0.010274,0.008205,0.004620,0.009239]},{w:"47",p:[0.864761,0.971012,0.897116,0.971012,0.897116,0.940075,0.864761,0.940075,0.015815,0.016540]},{w:"Research Publications",p:[0.663855,0.063855,0.886194,0.063855,0.886194,0.040840,0.663855,0.040840,0.016980,0.010442,0.009149,0.010442,0.011759,0.010014,0.010442,0.013076,0.005880,0.014370,0.013076,0.013076,0.006538,0.006538,0.010442,0.011759,0.007832,0.006538,0.011759,0.013076,0.009149]},{w:"Pharmacotherapy",p:[0.378766,0.106580,0.602195,0.106580,0.602195,0.077952,0.378766,0.077952,0.018475,0.016812,0.015119,0.011763,0.023525,0.015119,0.013426,0.015119,0.008406,0.016812,0.013426,0.011763,0.015119,0.015119,0.013426]},{w:"First published: 18 May 2023",p:[0.367924,0.128149,0.613034,0.128149,0.613034,0.109063,0.367924,0.109063,0.013446,0.005604,0.007842,0.006632,0.006632,0.005040,0.010079,0.011208,0.010079,0.005604,0.005604,0.007842,0.011208,0.008950,0.010079,0.006713,0.005040,0.010079,0.010079,0.005040,0.017921,0.010079,0.008950,0.005040,0.010079,0.010079,0.010079,0.010079]},{w:"Esraa A. Haroun , ",p:[0.104762,0.321498,0.255930,0.321498,0.255930,0.302298,0.104762,0.302298,0.012317,0.007842,0.006713,0.008950,0.008950,0.004634,0.014555,0.005040,0.005753,0.014555,0.008950,0.006713,0.010079,0.010079,0.010079,0.005878,0.005040,0.005040]},{w:"1",p:[0.239974,0.314927,0.245851,0.314927,0.245851,0.303734,0.239974,0.303734,0.005876]},{w:"Noha O. Mansour",p:[0.256642,0.321797,0.413189,0.321797,0.413189,0.302070,0.256642,0.302070,0.014555,0.010079,0.011208,0.010079,0.005759,0.015683,0.005040,0.005745,0.019030,0.010079,0.011208,0.007842,0.010079,0.011208,0.008950]},{w:"1",p:[0.413195,0.315101,0.419071,0.315101,0.419071,0.303600,0.413195,0.303600,0.005876]},{w:", Ahmed  evaluated through common terminology criteria ",p:[0.419071,0.321498,0.900306,0.321498,0.900306,0.302298,0.419071,0.302298,0.005040,0.004641,0.014555,0.010079,0.015683,0.008950,0.010079,0.005040,0.018766,0.008950,0.010079,0.008950,0.005604,0.010079,0.008950,0.005604,0.008950,0.010079,0.004290,0.005604,0.010079,0.006713,0.010079,0.010079,0.010079,0.010079,0.004308,0.008950,0.010079,0.015683,0.015683,0.010079,0.010079,0.004308,0.005604,0.008950,0.006713,0.015683,0.005604,0.010079,0.010079,0.005604,0.010079,0.010079,0.010079,0.004294,0.008950,0.006713,0.005604,0.005604,0.008950,0.006713,0.005604,0.008950,0.005040]},{w:"Eltantawy  , Mohamed E. E.Shams",p:[0.104762,0.338602,0.391032,0.338602,0.391032,0.319403,0.104762,0.319403,0.012317,0.005604,0.005604,0.008950,0.010079,0.005604,0.008950,0.014555,0.010079,0.005860,0.005854,0.005040,0.005854,0.017921,0.010079,0.010079,0.008950,0.015683,0.008950,0.010079,0.005848,0.012317,0.005040,0.005850,0.012317,0.005040,0.011208,0.010079,0.008950,0.015683,0.007842]},{w:"2",p:[0.186489,0.332031,0.192366,0.332031,0.192366,0.320838,0.186489,0.320838,0.005876]},{w:"1 ",p:[0.391029,0.332031,0.399843,0.332031,0.399843,0.320838,0.391029,0.320838,0.005876,0.002938]},{w:"1",p:[0.104762,0.355870,0.110638,0.355870,0.110638,0.344676,0.104762,0.344676,0.005876]},{w:"  Clinical  Pharmacy  and  Pharmacy  Practice ",p:[0.110638,0.362441,0.493160,0.362441,0.493160,0.343241,0.110638,0.343241,0.005040,0.006640,0.013446,0.005604,0.005604,0.010079,0.005604,0.008950,0.008950,0.005604,0.005040,0.006634,0.011208,0.010079,0.008950,0.006713,0.015683,0.008950,0.008950,0.010079,0.005040,0.006628,0.008950,0.010079,0.010079,0.005040,0.006638,0.011208,0.010079,0.008950,0.006713,0.015683,0.008950,0.008950,0.010079,0.005040,0.006630,0.011208,0.006713,0.008950,0.008950,0.005604,0.005604,0.008950,0.008950,0.005040]},{w:"Department,  Faculty  of  Pharmacy,  Mansoura ",p:[0.104762,0.379545,0.493134,0.379545,0.493134,0.360346,0.104762,0.360346,0.014555,0.008950,0.010079,0.008950,0.006713,0.005604,0.015683,0.008950,0.010079,0.005604,0.005040,0.005040,0.005177,0.011208,0.008950,0.008950,0.010079,0.005604,0.005604,0.010079,0.005040,0.005183,0.010079,0.006713,0.005040,0.005193,0.011208,0.010079,0.008950,0.006713,0.015683,0.008950,0.008950,0.008761,0.005040,0.005040,0.005193,0.017921,0.008950,0.010079,0.007842,0.010079,0.010079,0.006713,0.008950,0.005040]},{w:"University,  Mansoura,  Egypt.",p:[0.104762,0.396650,0.360614,0.396650,0.360614,0.377450,0.104762,0.377450,0.014555,0.010079,0.005604,0.010079,0.008950,0.006713,0.007842,0.005604,0.005604,0.008763,0.005040,0.005040,0.009043,0.017921,0.008950,0.010079,0.007842,0.010079,0.010079,0.006713,0.008950,0.005040,0.005040,0.009043,0.012317,0.010079,0.010079,0.010079,0.005604,0.005040]},{w:"2",p:[0.104762,0.413917,0.110638,0.413917,0.110638,0.402723,0.104762,0.402723,0.005876]},{w:"  Medical  Oncology  Unit,  Oncology  Center, ",p:[0.110638,0.420488,0.493136,0.420488,0.493136,0.401288,0.110638,0.401288,0.005040,0.005673,0.017921,0.008950,0.010079,0.005604,0.008950,0.008950,0.005604,0.005040,0.005657,0.014555,0.010079,0.008950,0.010079,0.005604,0.010079,0.010079,0.010079,0.005040,0.005669,0.014555,0.010079,0.005604,0.005604,0.005040,0.005040,0.005671,0.014555,0.010079,0.008950,0.010079,0.005604,0.010079,0.010079,0.010079,0.005040,0.005671,0.013446,0.008950,0.010079,0.005604,0.008950,0.005896,0.005040,0.005040]},{w:"Mansoura  University,  Mansoura,  Egypt.",p:[0.104762,0.437592,0.454020,0.437592,0.454020,0.418393,0.104762,0.418393,0.017921,0.008950,0.010079,0.007842,0.010079,0.010079,0.006713,0.008950,0.005040,0.008614,0.014555,0.010079,0.005604,0.010079,0.008950,0.006713,0.007842,0.005604,0.005604,0.008759,0.005040,0.005040,0.008614,0.017921,0.008950,0.010079,0.007842,0.010079,0.010079,0.006713,0.008950,0.005040,0.005040,0.008614,0.012317,0.010079,0.010079,0.010079,0.005604,0.005040]},{w:"Abstract",p:[0.104762,0.461431,0.174027,0.461431,0.174027,0.442345,0.104762,0.442345,0.013446,0.010079,0.006632,0.006632,0.007842,0.010079,0.008950,0.005604]},{w:"Study Objective:",p:[0.104762,0.485568,0.248633,0.485568,0.248633,0.465841,0.104762,0.465841,0.011208,0.006713,0.011208,0.011208,0.010079,0.003889,0.015683,0.011208,0.006713,0.008950,0.008950,0.006713,0.005604,0.010079,0.008950,0.006713]},{w:" Paclitaxel-induced peripheral ",p:[0.248620,0.485269,0.493149,0.485269,0.493149,0.466069,0.248620,0.466069,0.003879,0.011208,0.008950,0.008950,0.005604,0.005604,0.005604,0.008950,0.010079,0.008932,0.005604,0.006713,0.005604,0.010079,0.010079,0.010079,0.008950,0.008950,0.010079,0.003864,0.010079,0.008950,0.006713,0.005604,0.010079,0.010079,0.008950,0.006713,0.008950,0.005604,0.005040]},{w:"neuropathy  is  a  significant  clinical  problem ",p:[0.104762,0.502373,0.493154,0.502373,0.493154,0.483174,0.104762,0.483174,0.010079,0.008950,0.010079,0.006713,0.010079,0.010079,0.008950,0.005604,0.010079,0.010079,0.005040,0.006902,0.005604,0.007842,0.005040,0.006914,0.008950,0.005040,0.006910,0.007842,0.005604,0.010079,0.010079,0.005604,0.005604,0.005604,0.008950,0.008950,0.010079,0.005604,0.005040,0.006910,0.008950,0.005604,0.005604,0.010079,0.005604,0.008950,0.008950,0.005604,0.005040,0.006888,0.010079,0.006713,0.010079,0.010079,0.005604,0.008950,0.015683,0.005040]},{w:"can  markedly  deteriorate  patient’s  quality  of ",p:[0.104762,0.519478,0.493138,0.519478,0.493138,0.500278,0.104762,0.500278,0.008950,0.008950,0.010079,0.005040,0.005350,0.015683,0.008950,0.006713,0.010079,0.008950,0.010079,0.005604,0.010079,0.005040,0.005346,0.010079,0.008950,0.005604,0.008950,0.006713,0.005604,0.010079,0.006713,0.008950,0.005604,0.008950,0.005040,0.005332,0.010079,0.008950,0.005604,0.005604,0.008950,0.010079,0.005604,0.005584,0.007842,0.005040,0.005358,0.010079,0.010079,0.008950,0.005604,0.005604,0.005604,0.010079,0.005040,0.005342,0.010079,0.006713,0.005040]},{w:"life  (QoL).  Preclinical  evidence  exists  about ",p:[0.104762,0.536582,0.493146,0.536582,0.493146,0.517383,0.104762,0.517383,0.005604,0.005604,0.006713,0.008950,0.005040,0.005515,0.006713,0.014555,0.010079,0.012317,0.006713,0.005040,0.005040,0.005523,0.011208,0.006713,0.008950,0.008950,0.005604,0.005604,0.010079,0.005604,0.008950,0.008950,0.005604,0.005040,0.005503,0.008950,0.010079,0.005604,0.010079,0.008950,0.010079,0.008950,0.008950,0.005040,0.005511,0.008950,0.010079,0.005604,0.006572,0.006572,0.007842,0.005040,0.005530,0.008950,0.010079,0.010079,0.010079,0.005604,0.005040]},{w:"the  preventive  capacity  of  cilostazol  against ",p:[0.104762,0.553687,0.493138,0.553687,0.493138,0.534487,0.104762,0.534487,0.005604,0.010079,0.008950,0.005040,0.006140,0.010079,0.006713,0.008950,0.010079,0.008950,0.010079,0.005604,0.005604,0.010079,0.008950,0.005040,0.006130,0.008950,0.008950,0.010079,0.008950,0.008950,0.005604,0.005604,0.010079,0.005040,0.006128,0.010079,0.006713,0.005040,0.006146,0.008950,0.005604,0.005604,0.010079,0.006572,0.006572,0.008950,0.008950,0.010079,0.005604,0.005040,0.006134,0.008950,0.010079,0.008950,0.005604,0.010079,0.006572,0.006572,0.005040]},{w:"peripheral neuropathy. However, this hypothesis ",p:[0.104762,0.570791,0.493134,0.570791,0.493134,0.551591,0.104762,0.551591,0.010079,0.008950,0.006713,0.005604,0.010079,0.010079,0.008950,0.006713,0.008950,0.005604,0.003417,0.010079,0.008950,0.010079,0.006713,0.010079,0.010079,0.008950,0.005604,0.010079,0.008763,0.005040,0.003435,0.014555,0.010079,0.014555,0.008950,0.010079,0.008950,0.005898,0.005040,0.003435,0.005604,0.010079,0.005604,0.007842,0.003429,0.010079,0.010079,0.010079,0.010079,0.005604,0.010079,0.008950,0.007842,0.005604,0.007842,0.005040]},{w:"has  not  yet  been  clinically  investigated.  This ",p:[0.104762,0.587895,0.493138,0.587895,0.493138,0.568696,0.104762,0.568696,0.010079,0.008950,0.007842,0.005040,0.004193,0.010079,0.010079,0.005604,0.005040,0.004187,0.010079,0.008950,0.005604,0.005040,0.004187,0.010079,0.008950,0.008950,0.010079,0.005040,0.004185,0.008950,0.005604,0.005604,0.010079,0.005604,0.008950,0.008950,0.005604,0.005578,0.010079,0.005040,0.004193,0.005604,0.010079,0.010079,0.008950,0.006572,0.006572,0.005604,0.010079,0.008950,0.005604,0.008950,0.010079,0.005040,0.005040,0.003814,0.012317,0.010079,0.005604,0.007842,0.005040]},{w:"proof-of-concept  study  evaluated  the  effect ",p:[0.104762,0.605000,0.493148,0.605000,0.493148,0.585800,0.104762,0.585800,0.010079,0.006713,0.010079,0.010079,0.006713,0.006713,0.010079,0.006713,0.006713,0.008950,0.010079,0.010079,0.008950,0.008950,0.010079,0.005604,0.005040,0.009174,0.006572,0.006572,0.010079,0.010079,0.010079,0.005040,0.009194,0.008950,0.010079,0.008950,0.005604,0.010079,0.008950,0.005604,0.008950,0.010079,0.005040,0.009168,0.005604,0.010079,0.008950,0.005040,0.009180,0.008950,0.006088,0.006088,0.008950,0.008950,0.005604,0.005040]},{w:"of  cilostazol  on  the  incidence  of  paclitaxel-",p:[0.104762,0.622104,0.488120,0.622104,0.488120,0.602904,0.104762,0.602904,0.010079,0.006713,0.005040,0.005913,0.008950,0.005604,0.005604,0.010069,0.006572,0.006572,0.008950,0.008950,0.010079,0.005604,0.005040,0.005911,0.010079,0.010079,0.005040,0.005913,0.005604,0.010079,0.008950,0.005040,0.005907,0.005604,0.010079,0.008950,0.005604,0.010069,0.008950,0.010079,0.008950,0.008950,0.005040,0.005904,0.010079,0.006713,0.005040,0.005913,0.010079,0.008950,0.008950,0.005604,0.005604,0.005604,0.008950,0.010079,0.008950,0.005604,0.006713]},{w:"induced peripheral neuropathy in patients with ",p:[0.104762,0.639208,0.493150,0.639208,0.493150,0.620009,0.104762,0.620009,0.005604,0.010079,0.010079,0.010079,0.008950,0.008950,0.010079,0.006572,0.010079,0.008950,0.006713,0.005604,0.010079,0.010079,0.008950,0.006713,0.008950,0.005604,0.006572,0.010079,0.008950,0.010079,0.006713,0.010079,0.010079,0.008950,0.005604,0.010079,0.010079,0.006578,0.005604,0.010079,0.006580,0.010079,0.008950,0.005604,0.005604,0.008950,0.010079,0.005604,0.007842,0.006568,0.014555,0.005604,0.005604,0.010079,0.005040]},{w:"non-metastatic  breast  cancer.",p:[0.104762,0.656313,0.351815,0.656313,0.351815,0.637113,0.104762,0.637113,0.010079,0.010079,0.010079,0.006713,0.015683,0.008950,0.005604,0.008950,0.006572,0.006572,0.008950,0.005604,0.005604,0.008950,0.005040,0.007108,0.010079,0.006713,0.008950,0.008950,0.006572,0.006572,0.005040,0.007128,0.008950,0.008950,0.010079,0.008950,0.008950,0.005588,0.005040]},{w:"Design:",p:[0.104762,0.680451,0.169713,0.680451,0.169713,0.660723,0.104762,0.660723,0.014555,0.008950,0.007842,0.005604,0.010079,0.011208,0.006713]},{w:" This is a parallel randomized placebo-",p:[0.169717,0.680151,0.488107,0.680151,0.488107,0.660952,0.169717,0.660952,0.005558,0.012317,0.010079,0.005604,0.007842,0.005917,0.005604,0.007842,0.005921,0.008950,0.005919,0.010079,0.008950,0.006713,0.008950,0.005604,0.005604,0.008950,0.005604,0.005902,0.006713,0.008950,0.010079,0.010079,0.010079,0.015683,0.005604,0.008950,0.008950,0.010079,0.005904,0.010079,0.005604,0.008950,0.008950,0.008950,0.010079,0.010079,0.006713]},{w:"controlled trial.",p:[0.104762,0.697256,0.230782,0.697256,0.230782,0.678056,0.104762,0.678056,0.008950,0.010079,0.010079,0.005604,0.006713,0.010079,0.005604,0.005604,0.008950,0.010079,0.006761,0.005604,0.006713,0.005604,0.008950,0.005604,0.005040]},{w:"Setting:",p:[0.104762,0.721393,0.171951,0.721393,0.171951,0.701666,0.104762,0.701666,0.011208,0.008950,0.006713,0.006713,0.005604,0.011208,0.010079,0.006713]},{w:"  The  Oncology  Center  at  Mansoura ",p:[0.171951,0.721094,0.493134,0.721094,0.493134,0.701894,0.171951,0.701894,0.005040,0.005949,0.012317,0.010079,0.008950,0.005040,0.006308,0.014555,0.010079,0.008950,0.010079,0.005604,0.010079,0.010079,0.010079,0.005040,0.006312,0.013446,0.008950,0.010079,0.005604,0.008950,0.006713,0.005040,0.006304,0.008950,0.005604,0.005040,0.006308,0.017921,0.008950,0.010079,0.007842,0.010079,0.010079,0.006713,0.008950,0.005040]},{w:"University,  Egypt.",p:[0.104762,0.738198,0.265034,0.738198,0.265034,0.718999,0.104762,0.718999,0.014555,0.010079,0.005604,0.010079,0.008950,0.006713,0.007842,0.005604,0.005604,0.008763,0.005040,0.005040,0.013200,0.012317,0.010079,0.010079,0.010079,0.005604,0.005040]},{w:"Patients:",p:[0.104762,0.762336,0.180901,0.762336,0.180901,0.742609,0.104762,0.742609,0.012317,0.010079,0.006713,0.005604,0.008950,0.011208,0.006713,0.007842,0.006713]},{w:" Patients with breast cancer scheduled  improve the patients’ QoL. Future larger clinical ",p:[0.180898,0.762037,0.900300,0.762575,0.900300,0.743376,0.180898,0.742837,0.005300,0.011208,0.008950,0.005604,0.005604,0.008950,0.010079,0.005604,0.007842,0.005290,0.014555,0.005604,0.005604,0.010079,0.005298,0.010079,0.006713,0.008950,0.008950,0.006572,0.006572,0.005300,0.008950,0.008950,0.010079,0.008950,0.008950,0.006713,0.005290,0.007842,0.008950,0.010079,0.008950,0.010079,0.010079,0.005604,0.008950,0.010079,0.005040,0.018760,0.005604,0.015683,0.010079,0.006713,0.010079,0.010079,0.008950,0.003828,0.005604,0.010079,0.008950,0.003830,0.010079,0.008950,0.005604,0.005604,0.008950,0.010079,0.005604,0.007842,0.005205,0.003838,0.014555,0.010079,0.012317,0.005040,0.003836,0.011208,0.010079,0.005604,0.010079,0.006713,0.008950,0.003834,0.005604,0.008950,0.006344,0.010079,0.008950,0.006713,0.003834,0.008950,0.005604,0.005604,0.010079,0.005604,0.008950,0.008950,0.005604,-0.532321]},{w:"to receive paclitaxel 175 mg/m2 biweekly.",p:[0.104762,0.779141,0.447315,0.779141,0.447315,0.759941,0.104762,0.759941,0.005604,0.010079,0.005328,0.006713,0.008950,0.008950,0.008950,0.005604,0.010079,0.008950,0.005314,0.010079,0.008950,0.008950,0.005604,0.005604,0.005604,0.008950,0.010079,0.008950,0.005604,0.005306,0.010079,0.010079,0.010079,0.004032,0.015683,0.010079,0.005604,0.015683,0.010079,0.005324,0.010079,0.005604,0.014555,0.008950,0.008950,0.010079,0.005604,0.008761,0.005040]},{w:"Interventions:",p:[0.104762,0.803279,0.226823,0.803279,0.226823,0.783552,0.104762,0.783552,0.007842,0.011208,0.006713,0.008950,0.008950,0.010079,0.008950,0.011208,0.006713,0.005604,0.010079,0.011208,0.007842,0.006713]},{w:"  Patients  were  randomized  to ",p:[0.226826,0.802979,0.493135,0.802979,0.493135,0.783780,0.226826,0.783780,0.005040,0.006820,0.011208,0.008950,0.005604,0.005604,0.008950,0.010079,0.005604,0.007842,0.005040,0.006810,0.014555,0.008950,0.006713,0.008950,0.005040,0.006814,0.006713,0.008950,0.010079,0.010079,0.010079,0.015683,0.005604,0.008950,0.008950,0.010079,0.005040,0.006804,0.005604,0.010079,0.005040]},{w:"either cilostazol group who received cilostazol ",p:[0.104762,0.820084,0.493152,0.820084,0.493152,0.800884,0.104762,0.800884,0.008950,0.005604,0.005604,0.010079,0.008950,0.006713,0.006693,0.008950,0.005604,0.005604,0.010079,0.006572,0.006572,0.008950,0.008950,0.010079,0.005604,0.006701,0.010079,0.006713,0.010079,0.010079,0.010079,0.006707,0.014555,0.010079,0.010079,0.006705,0.006713,0.008950,0.008950,0.008950,0.005604,0.010079,0.008950,0.010079,0.006691,0.008950,0.005604,0.005604,0.010079,0.006572,0.006572,0.008950,0.008950,0.010079,0.005604,0.005040]},{w:"tablets  100 mg  BID,  or  to  control  group  who ",p:[0.104762,0.837188,0.493134,0.837188,0.493134,0.817989,0.104762,0.817989,0.005604,0.008950,0.010079,0.005604,0.008950,0.005604,0.007842,0.005040,0.003461,0.010079,0.010079,0.010079,0.004032,0.015683,0.010079,0.005040,0.003473,0.013446,0.006713,0.014555,0.005040,0.005040,0.003479,0.010079,0.006713,0.005040,0.003475,0.005604,0.010079,0.005040,0.003475,0.008950,0.010079,0.010079,0.005604,0.006713,0.010079,0.005604,0.005040,0.003465,0.010079,0.006713,0.010079,0.010079,0.010079,0.005040,0.003475,0.014555,0.010079,0.010079,0.005040]},{w:"received  placebo  instead.",p:[0.104762,0.854293,0.318896,0.854293,0.318896,0.835093,0.104762,0.835093,0.006713,0.008950,0.008950,0.008950,0.005604,0.010079,0.008950,0.010079,0.005040,0.005616,0.010079,0.005604,0.008950,0.008950,0.008950,0.010079,0.010079,0.005040,0.005620,0.005604,0.010079,0.006572,0.006572,0.008950,0.008950,0.010079,0.005040]},{w:"Measurements:",p:[0.104762,0.878430,0.237624,0.878430,0.237624,0.858703,0.104762,0.858703,0.019030,0.008950,0.010079,0.007842,0.011208,0.008584,0.008950,0.016792,0.008950,0.011208,0.006713,0.007842,0.006713]},{w:"  The  primary  endpoint  was ",p:[0.237624,0.878131,0.493138,0.878131,0.493138,0.858931,0.237624,0.858931,0.005040,0.008043,0.012317,0.010079,0.008950,0.005040,0.008400,0.010079,0.006713,0.005604,0.015683,0.008950,0.006713,0.010079,0.005040,0.008404,0.008950,0.010079,0.010079,0.010079,0.010079,0.005604,0.010079,0.005604,0.005040,0.008396,0.014555,0.008950,0.007842,0.005040]},{w:"the incidence of paclitaxel-induced neuropathy ",p:[0.104762,0.895235,0.493144,0.895235,0.493144,0.876036,0.104762,0.876036,0.005604,0.010079,0.008950,0.006273,0.005604,0.010079,0.008950,0.005604,0.010079,0.008950,0.010079,0.008950,0.008932,0.006279,0.010079,0.006713,0.006281,0.010079,0.008950,0.008950,0.005604,0.005604,0.005604,0.008950,0.010079,0.008950,0.005604,0.006713,0.005604,0.010079,0.010079,0.010079,0.008950,0.008950,0.010079,0.006245,0.010079,0.008950,0.010079,0.006713,0.010079,0.010079,0.008950,0.005604,0.010079,0.010079,0.005040]},{w:"Effect of cilostazol on preventing paclitaxel-induced ",p:[0.176564,0.169937,0.831068,0.169937,0.831068,0.141308,0.176564,0.141308,0.020169,0.009041,0.009041,0.013426,0.013426,0.008406,0.007560,0.015119,0.010069,0.007560,0.013426,0.008406,0.008406,0.015119,0.009948,0.009948,0.015119,0.011763,0.015119,0.008406,0.007560,0.015119,0.016812,0.007560,0.015119,0.011763,0.013426,0.013426,0.013426,0.016812,0.008406,0.008406,0.016812,0.015119,0.007560,0.015119,0.015119,0.013426,0.008406,0.008406,0.008406,0.015119,0.015119,0.013426,0.008406,0.010069,0.008406,0.016812,0.015119,0.016812,0.013426,0.013426,0.015119,0.007560]},{w:"neuropathy in patients with breast cancer: A randomized ",p:[0.147456,0.193693,0.860104,0.193693,0.860104,0.165064,0.147456,0.165064,0.016812,0.013426,0.016812,0.011763,0.015119,0.015119,0.015119,0.008406,0.016812,0.013426,0.007560,0.008406,0.016812,0.007560,0.015119,0.015119,0.008406,0.008406,0.013426,0.016812,0.008406,0.011763,0.007560,0.020169,0.008406,0.008406,0.016812,0.007560,0.015119,0.011763,0.013426,0.015119,0.009948,0.009948,0.007560,0.013426,0.015119,0.016812,0.013426,0.013426,0.011763,0.010069,0.006413,0.018500,0.007560,0.011763,0.015119,0.016812,0.015119,0.015119,0.023525,0.008406,0.011763,0.013426,0.015119,0.007560]},{w:"controlled trial",p:[0.407181,0.217449,0.592843,0.217449,0.592843,0.188820,0.407181,0.188820,0.013426,0.015119,0.016812,0.008406,0.011763,0.015119,0.008406,0.008406,0.013426,0.015119,0.007560,0.008406,0.011763,0.008406,0.015119,0.008406]},{w:"for  adverse  event  (NCI-CTCAE)  version  4. ",p:[0.511904,0.338602,0.900274,0.338602,0.900274,0.319403,0.511904,0.319403,0.006713,0.010079,0.006713,0.005040,0.006804,0.008950,0.010079,0.010079,0.008950,0.006713,0.007842,0.008950,0.005040,0.006800,0.008950,0.010079,0.008950,0.010079,0.005604,0.005040,0.006793,0.006713,0.014555,0.013446,0.006713,0.006713,0.013446,0.012317,0.013446,0.014555,0.012317,0.006713,0.005040,0.006802,0.010079,0.008950,0.006713,0.007842,0.005604,0.010079,0.010079,0.005040,0.006802,0.010079,0.005040,0.005040]},{w:"Secondary endpoints included assessment of the ",p:[0.511904,0.355707,0.900284,0.355707,0.900284,0.336507,0.511904,0.336507,0.011208,0.008950,0.008950,0.010079,0.010079,0.010079,0.008950,0.006713,0.010079,0.003883,0.008950,0.010079,0.010079,0.010079,0.010079,0.005604,0.010079,0.005604,0.007842,0.003883,0.005604,0.010079,0.008950,0.005604,0.010079,0.010079,0.008950,0.010079,0.003875,0.008950,0.007842,0.007842,0.008950,0.007842,0.007842,0.015683,0.008950,0.010079,0.005604,0.003887,0.010079,0.006713,0.003889,0.005604,0.010079,0.008950,0.005040]},{w:"patient’s QoL by the Functional Assessment of ",p:[0.511904,0.372811,0.900284,0.372811,0.900284,0.353612,0.511904,0.353612,0.010079,0.008950,0.005604,0.005604,0.008950,0.010079,0.005604,0.005584,0.007842,0.006161,0.014555,0.010079,0.011569,0.006158,0.010079,0.010079,0.006156,0.005604,0.010079,0.008950,0.006150,0.011208,0.010079,0.010079,0.008950,0.005604,0.005604,0.010079,0.010079,0.008950,0.005604,0.005040,0.014555,0.007842,0.007842,0.008950,0.007842,0.007842,0.015683,0.008950,0.010079,0.005604,0.006161,0.010079,0.006713,0.005040]},{w:"Cancer Therapy/Gynecologic Oncology Group-",p:[0.511904,0.389916,0.895243,0.389916,0.895243,0.370716,0.511904,0.370716,0.013446,0.008950,0.010079,0.008950,0.008950,0.006713,0.004004,0.012317,0.010079,0.008950,0.006713,0.008950,0.010079,0.010079,0.005604,0.014555,0.010079,0.010079,0.008950,0.008950,0.010079,0.005604,0.010079,0.010069,0.005604,0.008950,0.004372,0.014555,0.010079,0.008950,0.010079,0.005604,0.010079,0.010079,0.010079,0.004374,0.014555,0.006713,0.010079,0.010079,0.010079,0.006713]},{w:"Neurotoxicity  (FACT-GOG-NTx)  subscale. ",p:[0.511904,0.407020,0.900274,0.407020,0.900274,0.387820,0.511904,0.387820,0.014555,0.008950,0.010079,0.006713,0.010079,0.005604,0.010079,0.010079,0.005604,0.008950,0.005604,0.005604,0.010079,0.005040,0.016133,0.006713,0.009714,0.014555,0.013446,0.010466,0.006713,0.014555,0.014555,0.014555,0.006713,0.014555,0.012317,0.010079,0.006713,0.005040,0.016151,0.007842,0.010079,0.010079,0.007842,0.008950,0.008950,0.005604,0.008950,0.005040,0.005040]},{w:"Exploratory  outcome  measures  included ",p:[0.511904,0.424124,0.900290,0.424124,0.900290,0.404925,0.511904,0.404925,0.012317,0.010079,0.010079,0.005604,0.010079,0.006713,0.008950,0.005604,0.010079,0.006713,0.010079,0.005040,0.019352,0.010079,0.010079,0.005604,0.008950,0.010079,0.015683,0.008950,0.005040,0.019352,0.015683,0.008950,0.008950,0.007842,0.010079,0.006713,0.008950,0.007842,0.005040,0.019360,0.005604,0.010079,0.008950,0.005604,0.010079,0.010079,0.008950,0.010079,0.005040]},{w:"changes in serum levels of biomarkers namely ",p:[0.511904,0.441229,0.900290,0.441229,0.900290,0.422029,0.511904,0.422029,0.008950,0.010079,0.008950,0.010079,0.010079,0.008950,0.007842,0.006600,0.005604,0.010079,0.006602,0.007842,0.008950,0.006713,0.010079,0.015683,0.006600,0.005604,0.008950,0.010079,0.008950,0.005604,0.007842,0.006596,0.010079,0.006713,0.006606,0.010079,0.005604,0.010079,0.015683,0.008950,0.006713,0.010079,0.008950,0.006713,0.007842,0.006596,0.010079,0.008950,0.015683,0.008950,0.005604,0.010079,0.005040]},{w:"nerve growth factor (NGF), and neurofilament ",p:[0.511904,0.458333,0.900294,0.458333,0.900294,0.439133,0.511904,0.439133,0.010079,0.008950,0.006713,0.010079,0.008950,0.006912,0.010079,0.006713,0.010079,0.014555,0.005604,0.010079,0.006918,0.006713,0.008950,0.008950,0.005604,0.010079,0.006713,0.006908,0.006713,0.014555,0.014555,0.011208,0.006713,0.005040,0.006929,0.008950,0.010079,0.010079,0.006916,0.010079,0.008950,0.010079,0.006713,0.010079,0.005604,0.005604,0.005604,0.008950,0.015683,0.008950,0.010079,0.005604,0.005040]},{w:"light  chain  (NfL).",p:[0.511904,0.475437,0.661369,0.475437,0.661369,0.456238,0.511904,0.456238,0.005604,0.005604,0.010079,0.010079,0.005604,0.005040,0.003350,0.008950,0.010079,0.008950,0.005604,0.010079,0.005040,0.003350,0.006713,0.014555,0.006713,0.012317,0.006713,0.005040]},{w:"Main Results:",p:[0.511904,0.499575,0.635679,0.499575,0.635679,0.479848,0.511904,0.479848,0.019030,0.010079,0.005604,0.011208,0.008426,0.014555,0.008950,0.007842,0.011208,0.005604,0.006713,0.007842,0.006713]},{w:"  The  incidence  of  grade  2  and ",p:[0.635689,0.499276,0.900280,0.499276,0.900280,0.480076,0.635689,0.480076,0.005040,0.003030,0.012317,0.010079,0.008950,0.005040,0.003387,0.005604,0.010079,0.008950,0.005604,0.010079,0.008936,0.010079,0.008950,0.008950,0.005040,0.003389,0.010079,0.006713,0.005040,0.003393,0.010079,0.006713,0.008950,0.010079,0.008950,0.005040,0.003389,0.010079,0.005040,0.003393,0.008950,0.010079,0.010079,0.005040]},{w:"3  peripheral  neuropathies  were  significantly ",p:[0.511904,0.516380,0.900290,0.516380,0.900290,0.497181,0.511904,0.497181,0.010079,0.005040,0.007388,0.010079,0.008950,0.006713,0.005604,0.010079,0.010079,0.008950,0.006713,0.008950,0.005604,0.005040,0.007372,0.010079,0.008950,0.010079,0.006713,0.010079,0.010079,0.008950,0.005604,0.010079,0.005604,0.008950,0.007830,0.005040,0.007388,0.014555,0.008950,0.006713,0.008950,0.005040,0.007384,0.007842,0.005604,0.010079,0.010079,0.005604,0.005604,0.005604,0.008950,0.008950,0.010079,0.005604,0.005604,0.010079,0.005040]},{w:"lower in the cilostazol group (40%) compared ",p:[0.511904,0.533485,0.900294,0.533485,0.900294,0.514285,0.511904,0.514285,0.005604,0.010079,0.014555,0.008950,0.006713,0.007213,0.005604,0.010079,0.007217,0.005604,0.010079,0.008950,0.007209,0.008950,0.005604,0.005604,0.010079,0.006572,0.006572,0.008950,0.008950,0.010079,0.005604,0.007203,0.010079,0.006713,0.010079,0.010079,0.010079,0.007215,0.006713,0.010079,0.010079,0.016792,0.006713,0.007217,0.008950,0.010079,0.015683,0.010079,0.008950,0.006713,0.008950,0.010079,0.005040]},{w:"to  the  control  group  (86.7%)  (p < 0.001). The ",p:[0.511904,0.550589,0.900294,0.550589,0.900294,0.531389,0.511904,0.531389,0.005604,0.010079,0.005040,0.003137,0.005604,0.010079,0.008950,0.005040,0.003139,0.008950,0.010079,0.010079,0.005604,0.006713,0.010079,0.005604,0.005040,0.003137,0.010079,0.006713,0.010079,0.010079,0.010079,0.005040,0.003141,0.006713,0.010079,0.010079,0.005040,0.010079,0.016792,0.006713,0.005040,0.003141,0.006713,0.010079,0.004032,0.011370,0.004032,0.010079,0.005040,0.010079,0.010079,0.010079,0.006713,0.005040,0.007824,0.012317,0.010079,0.008950,0.005040]},{w:"incidence  of  clinically  significant  worsening ",p:[0.511904,0.567693,0.900276,0.567693,0.900276,0.548494,0.511904,0.548494,0.005604,0.010079,0.008950,0.005604,0.010079,0.008950,0.010079,0.008950,0.008950,0.005040,0.006525,0.010079,0.006713,0.005040,0.006544,0.008950,0.005604,0.005604,0.010079,0.005604,0.008950,0.008950,0.005604,0.005604,0.010079,0.005040,0.006517,0.007842,0.005604,0.010079,0.010079,0.005604,0.005604,0.005604,0.008950,0.008950,0.010079,0.005604,0.005040,0.006533,0.014555,0.010079,0.006713,0.007842,0.008950,0.010079,0.005604,0.010079,0.010079,0.005040]},{w:"in  neuropathy-related  QoL  was  higher  in ",p:[0.511904,0.584798,0.900284,0.584798,0.900284,0.565598,0.511904,0.565598,0.005604,0.010079,0.005040,0.011093,0.010079,0.008950,0.010079,0.006713,0.010079,0.010079,0.008950,0.005604,0.010079,0.010079,0.006713,0.006713,0.008950,0.005604,0.008950,0.005604,0.008950,0.010079,0.005040,0.011081,0.014555,0.010079,0.011565,0.005040,0.011097,0.014555,0.008950,0.007842,0.005040,0.011101,0.010079,0.005604,0.010079,0.010079,0.008950,0.006713,0.005040,0.011091,0.005604,0.010079,0.005040]},{w:"control group compared to the cilostazol group ",p:[0.511904,0.601902,0.900280,0.601902,0.900280,0.582702,0.511904,0.582702,0.008950,0.010079,0.010079,0.005604,0.006713,0.010079,0.005604,0.005896,0.010079,0.006713,0.010079,0.010079,0.010079,0.005907,0.008950,0.010079,0.015683,0.010079,0.008950,0.006713,0.008950,0.010079,0.005894,0.005604,0.010079,0.005907,0.005604,0.010079,0.008950,0.005900,0.008950,0.005604,0.005604,0.010079,0.006572,0.006572,0.008950,0.008950,0.010079,0.005604,0.005892,0.010079,0.006713,0.010079,0.010079,0.010079,0.005040]},{w:"(p = 0.001).  A  higher  percent  increase  from ",p:[0.511904,0.619006,0.900280,0.619006,0.900280,0.599807,0.511904,0.599807,0.006713,0.010079,0.004032,0.011370,0.004032,0.010079,0.005040,0.010079,0.010079,0.010079,0.006713,0.005040,0.005040,0.006183,0.013444,0.005040,0.007287,0.010079,0.005604,0.010079,0.010079,0.008950,0.006713,0.005040,0.007279,0.010079,0.008950,0.006713,0.008950,0.008950,0.010079,0.005604,0.005040,0.007275,0.005604,0.010079,0.008950,0.006713,0.008950,0.008950,0.007842,0.008950,0.005040,0.007273,0.006713,0.006713,0.010079,0.015683,0.005040]},{w:"baseline  in  serum  NGF  was  observed  in  the ",p:[0.511904,0.636111,0.900284,0.636111,0.900284,0.616911,0.511904,0.616911,0.010079,0.008950,0.007842,0.008950,0.005604,0.005604,0.010079,0.008950,0.005040,0.004602,0.005604,0.010079,0.005040,0.004612,0.007842,0.008950,0.006713,0.010079,0.015683,0.005040,0.004612,0.014555,0.014555,0.011208,0.005040,0.004624,0.014555,0.008950,0.007842,0.005040,0.004620,0.010079,0.010079,0.007842,0.008950,0.006713,0.010079,0.008950,0.010079,0.005040,0.004612,0.005604,0.010079,0.005040,0.004612,0.005604,0.010079,0.008950,0.005040]},{w:"cilostazol  group  (p = 0.043).  The  circulating ",p:[0.511904,0.653215,0.900292,0.653215,0.900292,0.634015,0.511904,0.634015,0.008950,0.005604,0.005604,0.010079,0.006572,0.006572,0.008950,0.008950,0.010079,0.005604,0.005040,0.007156,0.010079,0.006713,0.010079,0.010079,0.010079,0.005040,0.007168,0.006713,0.010079,0.004032,0.011370,0.004032,0.010079,0.005040,0.010079,0.010079,0.010079,0.006713,0.005040,0.005040,0.006806,0.012317,0.010079,0.008950,0.005040,0.007162,0.008950,0.005604,0.006713,0.008950,0.010079,0.005604,0.008950,0.005604,0.005604,0.010079,0.010079,0.005040]},{w:"levels of NfL deemed comparable between the ",p:[0.511904,0.670320,0.900290,0.670320,0.900290,0.651120,0.511904,0.651120,0.005604,0.008950,0.010079,0.008950,0.005604,0.007842,0.006356,0.010079,0.006713,0.006366,0.014555,0.006713,0.011569,0.006366,0.010079,0.008950,0.008950,0.015683,0.008950,0.010079,0.006352,0.008950,0.010079,0.015683,0.010079,0.008950,0.006713,0.008950,0.010079,0.005604,0.008950,0.006354,0.010079,0.008950,0.005604,0.014555,0.008950,0.008950,0.010079,0.006356,0.005604,0.010079,0.008950,0.005040]},{w:"two  arms  at  the  end  of  the  study  (p = 0.593).",p:[0.511904,0.687424,0.893715,0.687424,0.893715,0.668224,0.511904,0.668224,0.005604,0.014555,0.010079,0.005040,0.003205,0.008950,0.006713,0.015683,0.007842,0.005040,0.003205,0.008950,0.005604,0.005040,0.003197,0.005604,0.010079,0.008950,0.005040,0.003199,0.008950,0.010079,0.010079,0.005040,0.003203,0.010079,0.006713,0.005040,0.003205,0.005604,0.010079,0.008950,0.005040,0.003199,0.006572,0.006572,0.010079,0.010079,0.010079,0.005040,0.003211,0.006713,0.010079,0.004032,0.011370,0.004032,0.010079,0.005040,0.010079,0.010079,0.010079,0.006713,0.005040]},{w:"Conclusion:",p:[0.511904,0.711562,0.614956,0.711562,0.614956,0.691835,0.511904,0.691835,0.014555,0.010079,0.011208,0.008950,0.005604,0.011208,0.007842,0.005604,0.010079,0.011208,0.006713]},{w:" Adjunctive use of cilostazol is as ",p:[0.614962,0.711262,0.900276,0.711262,0.900276,0.692063,0.614962,0.692063,0.005715,0.014555,0.010079,0.005604,0.010079,0.010079,0.008950,0.005604,0.005604,0.010079,0.008950,0.006814,0.010079,0.007842,0.008950,0.006826,0.010079,0.006713,0.006828,0.008950,0.005604,0.005604,0.010079,0.006572,0.006572,0.008950,0.008950,0.010079,0.005604,0.006814,0.005604,0.007842,0.006826,0.008950,0.007842,0.005040]},{w:"a novel option that might reduce the incidence ",p:[0.511904,0.728367,0.900296,0.728367,0.900296,0.709167,0.511904,0.709167,0.008950,0.006461,0.010079,0.010079,0.010079,0.008950,0.005604,0.006455,0.010079,0.010079,0.005604,0.005604,0.010079,0.010079,0.006457,0.005604,0.010079,0.008950,0.005604,0.006453,0.015683,0.005604,0.010079,0.010079,0.005604,0.006453,0.006713,0.008950,0.010079,0.010079,0.008950,0.008950,0.006455,0.005604,0.010079,0.008950,0.006457,0.005604,0.010079,0.008950,0.005604,0.010079,0.008950,0.010079,0.008950,0.008950,0.005040]},{w:"of paclitaxel-induced peripheral neuropathy and ",p:[0.511904,0.745471,0.900286,0.745471,0.900286,0.726271,0.511904,0.726271,0.010079,0.006713,0.004042,0.010079,0.008950,0.008950,0.005604,0.005604,0.005604,0.008950,0.010079,0.008950,0.005604,0.006713,0.005574,0.010079,0.010079,0.010079,0.008950,0.008950,0.010079,0.004036,0.010079,0.008950,0.006713,0.005604,0.010079,0.010079,0.008950,0.006713,0.008950,0.005604,0.004032,0.010079,0.008950,0.010079,0.006713,0.010079,0.010079,0.008950,0.005604,0.010079,0.010079,0.004032,0.008950,0.010079,0.010079,0.005040]},{w:"trials are warranted to confirm these findings.",p:[0.511904,0.779680,0.879906,0.779680,0.879906,0.760480,0.511904,0.760480,0.005604,0.006713,0.005604,0.008950,0.005604,0.007842,0.005437,0.008950,0.006713,0.008950,0.005443,0.014555,0.008950,0.006713,0.006713,0.008950,0.010079,0.005604,0.008950,0.010079,0.005437,0.005604,0.010079,0.005441,0.008950,0.010079,0.010079,0.005604,0.005604,0.006713,0.015683,0.005443,0.005604,0.010079,0.008950,0.007842,0.008950,0.005441,0.005604,0.005604,0.010079,0.010079,0.005604,0.010079,0.010079,0.007842,0.005040]},{w:"https://doi.org/10.1002/phar.2830",p:[0.511904,0.803518,0.781999,0.803518,0.781999,0.784318,0.511904,0.784318,0.010079,0.005604,0.005604,0.010079,0.007842,0.005604,0.005604,0.005604,0.010079,0.010079,0.005604,0.005040,0.010079,0.006332,0.010079,0.005604,0.010079,0.010079,0.005040,0.010079,0.010079,0.010079,0.010079,0.005604,0.010079,0.010079,0.008950,0.005590,0.005040,0.010079,0.010079,0.010079,0.010079]}]};